Related Experiment Video
Updated: Aug 25, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Identification of tyrosine kinases overexpressed in head and neck cancer
Ho-Sheng Lin1, Gerald J Berry, Willard E Fee
1Department of Otolaryngology/Head and Neck Surgery, Wayne State University, Detroit, MI 48201, USA. hlin@med.wayne.edu
Objective:
To identify protein-tyrosine kinases (PTKs) that may be involved in the development and progression of head and neck squamous cell carcinoma (HNSCC).
Design:
Messenger RNA from 7 HNSCC specimens was reverse transcribed to complementary DNA, and selective amplification of PTK complementary DNA was achieved using polymerase chain reaction (PCR) with degenerate PTK primers. The resulting PTK PCR products from these 7 HNSCC specimens were then cloned and randomly selected for sequencing. The PTKs that were represented multiple times in these randomly selected clones were selected as candidate PTKs that may be overexpressed in HNSCC. Antibodies against these candidate PTKs were then used for immunohistochemical studies on 8 other HNSCC specimens not used in the original selection of the candidate PTKs.
Results:
Three known (EphA1, Brk, and Ron) and 2 novel (KIAA0728 and KIAA0279) PTKs were found to be highly expressed in the 7 HNSCC samples studied, based on the technique of reverse transcriptase-PCR with degenerate primers. Immunohistochemical studies with antibodies against the 3 known PTKs in 8 other HNSCC specimens not used in the previous reverse transcriptase-PCR reaction demonstrated overexpression of EphA1, Brk, and Ron in 12.5%, 37.5%, and 75% of these specimens.
Conclusions:
In this study, we identified 5 PTKs that were overexpressed in HNSCC using a reverse transcriptase-PCR technique and confirmed the overexpression of 3 known PTKs in some of the 8 archival HNSCC specimens studied. Our finding suggests that the signaling pathways mediated through EphA1, Brk, and Ron may be involved in the development and progression of HNSCC.
Insights
Researchers identified five protein-tyrosine kinases (PTKs) overexpressed in head and neck squamous cell carcinoma (HNSCC). EphA1, Brk, and Ron signaling pathways may drive HNSCC development and progression.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Head and neck squamous cell carcinoma (HNSCC) is a significant global health challenge.
- Understanding the molecular mechanisms driving HNSCC development and progression is crucial for targeted therapies.
Purpose of the Study:
- To identify novel and known protein-tyrosine kinases (PTKs) potentially involved in HNSCC pathogenesis.
- To investigate the expression patterns of candidate PTKs in HNSCC tissues.
Main Methods:
- Messenger RNA from HNSCC specimens was used for complementary DNA synthesis.
- Polymerase chain reaction (PCR) with degenerate PTK primers amplified PTK complementary DNA.
- Cloning, sequencing, and immunohistochemistry were employed to identify and validate PTK expression.
Main Results:
- Five PTKs, including EphA1, Brk, Ron, KIAA0728, and KIAA0279, were found to be highly expressed in HNSCC.
- Immunohistochemical analysis confirmed overexpression of EphA1, Brk, and Ron in 37.5% to 75% of HNSCC specimens.
Conclusions:
- This study identified five PTKs overexpressed in HNSCC.
- The findings suggest that signaling pathways involving EphA1, Brk, and Ron play a role in HNSCC development and progression.
More Related Videos
Related Concept Videos
Receptor Tyrosine Kinases
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle

